Elixir
Drug Screener
Login
×
Close
Searching Query
Please wait while we search for your query
Your search results are ready!
View Results
×
Close
Loading Screen
Please wait while we are loading your screen
Your screen is ready!
View Screen
×
Close
Examiner Insights
USPTO PAIR Documents
File History
PTAB Proceedings
Orange Book
Assignee Citation
Legal Events
SPC Events
Unitary Documents
Loading Examiner's Profile.
Loading USPTO PAIR Documents.
Loading PTAB Proceedings.
Loading Orange Book.
Loading Assignee Chart...
Loading Legal Events...
Loading SPC Events...
Loading Unitary Documents...
Loading File History...
Loading File History...
×
Close
Access Elixir Pro
Discover Your Next Blockbuster Drug
Popular Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View list
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View list
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View list
Therapeutic Themes
Top Revenue-Generating Cancer Drugs in 2024
Explore the highest-earning cancer drugs and their market impact
View list
High-Earning Generic Diabetes Drugs of the Year
Identify lucrative opportunities in the generic diabetes market
View list
Top Generic Heart Disease Drugs to Watch
Discover profitable generic heart disease treatments and their trends
View list
Best Revenue Generating Generic Asthma and COPD Drugs
Uncover the leading generics in asthma and COPD treatments
View list
Profitable Generic Infection Treatments
Examine the most lucrative generic options for infection treatments
View list
Top Generic Arthritis Drugs Driving Profits
Explore the leading generic arthritis drugs and their market influence
View list
Create your own
Last updated: October 11th, 2024
Actions
Patent Number
Company
Product
Brand
Approval Date
Revenue
Patent Expiry Date
Get updates in your inbox
Your Work Email:
*
* Please enter a valid email address
Message for us (Optional):